Navigation Links
Defense Department to Support Fragile X Research
Date:12/29/2009

WASHINGTON, Dec. 29 /PRNewswire-USNewswire/ -- The National Fragile X Foundation applauds the United States Congress and President Barack Obama for including Fragile X Syndrome for the first time ever within a select group of conditions eligible for research funding from the U.S. Department of Defense.

The new law, signed by President Obama on Dec. 19, designates $50 million through the FY 2010 Department of Defense Appropriations Act for the Peer Reviewed Medical Research Program (PRMRP). Fragile X is one of a select group of priority conditions that are eligible for funding under the PRMRP.

"We are thrilled that Congress and the President have recognized this need in our communities," said Robert Miller, Executive Director of The National Fragile X Foundation (NFXF). "Fragile X poses a serious challenge to families and communities everywhere, challenges that are much more acutely felt by our military families. This funding is a promise of support and a means to a better outcome for those affected by Fragile X."

Fragile X syndrome and its associated disorders are caused by a genetic mutation on the X chromosome and impact over one million Americans. Symptoms of Fragile X Syndrome include intellectual, physical and occupational disabilities. Behavioral problems, including autism, are also common among those with Fragile X.

"As the only Member of Congress who has a child with Fragile X, I understand the true value of priority designation for this genetic disorder," said Congressman Gregg Harper (R-Miss.). "Thousands of families across America are battling this disease and this research funding opens a new chapter of hope as we continue to learn how Fragile X impacts individuals. I'm thankful for the leadership of Senator Thad Cochran of Mississippi, the Ranking Republican on the Senate Appropriations Committee, who helped secure these federal dollars."

The National Fragile X Foundation funds and advocates for expanded Fragile X research, supports efforts to bring best medical practices to all impacted patients and their families, and promotes public awareness and education of Fragile X. The NFXF will work closely with the DoD to leverage this new investment in research to accelerate the march toward more effective targeted treatments and eventually a cure for Fragile X.

Through a NFXF sponsored program, since 2004 nearly 1000 grass roots advocates have visited their Members of Congress, advocating for innovative research funding and awareness initiatives.

SOURCE The National Fragile X Foundation


'/>"/>
SOURCE The National Fragile X Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science & Technology Conference
2. FY 2010 Federal Biodefense Spending
3. Powerful Image Registration and Recognition Software Unveiled for Medical, Satellite, and Defense Imaging Industries
4. NC Biomanufacturers Supply Defense for World vs. Flu
5. Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator
6. New Weapon in BioDefense Research: NanoLogix Kit Speeds Rapid Diagnostics of Anthrax and Bubonic Plague
7. ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security
8. PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting
9. Innovative Beverage Products Launches New Product Designed to Enhance the Bodys Immune Defense
10. Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury
11. Bell Ventures Launches Breakthrough Radical Defense Skin Care Ingredient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):